Updated as of July 23, 2020 Pharmacy Criteria Updates for Anti-Narcolepsy Drugs

Effective Aug. 9, 2020, the prior approval (PA) criteria and/or forms for anti-narcolepsy drugs will be updated. 

These changes will be implemented via system updates in the secure portal, as well as in existing paper drug forms and criteria on the public portal. Please see the summary of changes below.

Criteria Updates:

  • Provigil/Nuvigil PA drug class will change to Anti-Narcolepsy
  • Sunosi 
  • Wakix 

Form Updates:

  • Provigil/Nuvigil 
  • Sunosi
  • Wakix

 

M200157-R-1-2342